XML 317 R107.htm IDEA: XBRL DOCUMENT v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Sep. 30, 2024
Sep. 30, 2025
Dec. 31, 2024
Sep. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
General and administrative expenses $ 4,749,399     $ 1,125,121     $ 11,569,376   $ 3,546,510 $ 4,168,576 $ 5,274,603
OPERATING LOSS (8,398,352)     (2,565,663)     (18,446,251)   (8,067,782) (10,353,542) (14,238,899)
Other income (expense):                      
OTHER EXPENSE (880,853)     (184,345)     (3,333,974)   (1,344,689) (1,110,903) 74,792
Net loss attributable to common stockholders $ (9,279,205)     $ (2,810,304)     $ (21,780,225)   $ (9,527,605) $ (11,485,410) $ (13,908,462)
Weighted average shares outstanding (in Shares) 1,269,255     1,206,205     1,269,255   1,206,205 676,659 675,281
Basic net income per ordinary shares (in Dollars per share) $ (7.31)     $ (2.33)     $ (17.16)   $ (7.9) $ (16.97) $ (20.6)
Weighted-Average Shares of Common Shares Outstanding, Diluted (in shares) 1,269,255     1,206,205     1,269,255   1,206,205 676,659 675,281
Diluted net income per ordinary shares (in Dollars per share) $ (7.31)     $ (2.33)     $ (17.16)   $ (7.9) $ (16.97) $ (20.6)
HCM II ACQUISITION CORP                      
General and administrative expenses $ 1,638,082     $ 278,494   $ 331,157 $ 4,230,522 $ 634,797      
OPERATING LOSS (1,638,082)     (278,494)   (331,157) (4,230,522) (634,797)      
Other income (expense):                      
Interest earned on marketable securities held in Trust Account 2,508,797     1,349,715   1,349,715 7,449,387 4,043,585      
Initial loss on forward purchase agreement liability       (893,425)        
Change in fair value of forward purchase agreement liability 1,057,124       893,425        
OTHER EXPENSE 3,565,921     1,349,715   1,349,715 7,449,387 4,043,585      
Net loss attributable to common stockholders $ 1,927,839 $ 601,027 $ 689,999 $ 1,071,221 $ (52,663) $ 1,018,558 $ 3,218,865 $ 3,408,788      
Class A Ordinary Shares                      
Other income (expense):                      
Weighted average shares outstanding (in Shares)               11,372,694      
Basic net income per ordinary shares (in Dollars per share)               $ 0.2      
Diluted net income per ordinary shares (in Dollars per share) $ 0.07           $ 0.11        
Class A Ordinary Shares | HCM II ACQUISITION CORP                      
Other income (expense):                      
Weighted average shares outstanding (in Shares) 23,000,000     10,615,385   5,396,648 23,000,000 11,372,694      
Basic net income per ordinary shares (in Dollars per share) $ 0.07     $ 0.07   $ 0.09 $ 0.11 $ 0.2      
Weighted-Average Shares of Common Shares Outstanding, Diluted (in shares) 23,000,000     10,615,385   5,396,648 23,000,000        
Diluted net income per ordinary shares (in Dollars per share) $ 0.07     $ 0.07   $ 0.09 $ 0.11 $ 0.2      
Class B Ordinary Shares                      
Other income (expense):                      
Weighted average shares outstanding (in Shares)               5,297,048      
Basic net income per ordinary shares (in Dollars per share)               $ 0.2      
Diluted net income per ordinary shares (in Dollars per share) $ 0.07           $ 0.11        
Class B Ordinary Shares | HCM II ACQUISITION CORP                      
Other income (expense):                      
Weighted average shares outstanding (in Shares) 5,750,000 [1]     5,750,000 [1]   5,621,508 [1] 5,750,000 [1] 5,297,048      
Basic net income per ordinary shares (in Dollars per share) $ 0.07     $ 0.07   $ 0.09 $ 0.11 $ 0.2      
Weighted-Average Shares of Common Shares Outstanding, Diluted (in shares) 5,750,000     5,750,000   5,621,508 5,750,000        
Diluted net income per ordinary shares (in Dollars per share) $ 0.07     $ 0.07   $ 0.09 $ 0.11 $ 0.2      
[1] Excludes up to 750,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (Note 6). On August 19, 2024, the Company consummated its IPO and sold 23,000,000 Units, including 3,000,000 Units sold pursuant to the full exercise of the underwriters’ option to purchase additional units to cover the over-allotment, hence the 750,000 shares of Class B ordinary shares were no longer subject to forfeiture.